{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T21:44:35Z","timestamp":1770500675931,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"11-12","license":[{"start":{"date-parts":[[1997,11,1]],"date-time":"1997-11-01T00:00:00Z","timestamp":878342400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1997,11]]},"DOI":"10.1007\/bf01294731","type":"journal-article","created":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T23:02:31Z","timestamp":1111705351000},"page":"1305-1311","source":"Crossref","is-referenced-by-count":21,"title":["Clozapine-induced agranulocytosis and thrombopenia in a patient with dopaminergic psychosis"],"prefix":"10.1007","volume":"104","author":[{"given":"J.","family":"Rudolf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Grond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Neveling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. -D.","family":"Heiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJM199307153290303","volume":"329","author":"JM Alvir","year":"1993","unstructured":"Alvir JM, Lieberman JA, Safferman AZ, Schwimmer JL, Schaaf JA (1993) Clozapine-induced agranulocytosis: incidence and risk factors in the United States. N Engl J Med 329: 162?167","journal-title":"N Engl J Med"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1192\/bjp.169.4.483","volume":"169","author":"K Atkin","year":"1996","unstructured":"Atkin K, Kendall F, Gould D, Freeman H, Liberman J, O'Sullivan D (1996) Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. Br J Psychiatry 169: 483?488","journal-title":"Br J Psychiatry"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/00007611-199310000-00021","volume":"86","author":"R Durst","year":"1993","unstructured":"Durst R, Dorevitch A, Fraenkel Y (1993) Platelet dysfuction associated with clozapine therapy. South Med J 86: 1170?1172","journal-title":"South Med J"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/mds.870070205","volume":"7","author":"SA Factor","year":"1992","unstructured":"Factor SA, Brown D (1992) Clozapine prevents recurrence of psychosis in Parkinson's disease. Mov Disord 7: 125?131","journal-title":"Mov Disord"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/jnnp.51.4.529","volume":"51","author":"SA Factor","year":"1988","unstructured":"Factor SA, Sanchez-Ramos JR, Weiner WJ (1988) Parkinson's disease: an open trial of pergolide in patients failing bromocriptine therapy. J Neurol Neurosurg Psychiatry 51: 529?533","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1212\/WNL.44.3_Part_1.544","volume":"44","author":"SA Factor","year":"1994","unstructured":"Factor SA, Brown D, Molho ES, Podskalny GD (1994) Clozapine: a 2-year open trial in Parkinson's disease patients with psychosis. Neurology 44: 544?546","journal-title":"Neurology"},{"key":"CR7","first-page":"115","volume":"65","author":"SA Factor","year":"1995","unstructured":"Factor SA, Molho ES, Podskalny GD, Brown D (1995) Parkinson's disease: drug-induced psychiatric states. Adv Neurol 65: 115?138","journal-title":"Adv Neurol"},{"key":"CR8","first-page":"279","volume-title":"Harrison's principles of internal medicine","author":"JI Gallin","year":"1988","unstructured":"Gallin JI (1988) Disorders of phagocytic cells. In: Braunwald E, Isselbacher KJ, Petersdorf RG, Wilson JD, Martin JB, Fauci AS (eds) Harrison's principles of internal medicine, 11th edn. McGraw Hill, New York, pp 279?283","edition":"11th edn."},{"issue":"Suppl B","key":"CR9","first-page":"1389","volume":"55","author":"SL Gerson","year":"1994","unstructured":"Gerson SL (1994) G-CSF and the management of clozapine-induced agranulocytosis. J Clin Psychiatry 55 [Suppl B]: 1389?142","journal-title":"J Clin Psychiatry"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1001\/jama.1971.03190260031009","volume":"218","author":"FK Goodwin","year":"1971","unstructured":"Goodwin FK (1971) Psychiatric side effects of levodopa in man. JAMA 218: 1915?1929","journal-title":"JAMA"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17: 427?442","journal-title":"Neurology"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/s-2007-996615","volume":"63","author":"A Klimke","year":"1995","unstructured":"Klimke A, Klieser E (1995) Das atypische Neuroleptikum Clozapin (Leponex\ufffd)-aktueller Kenntnisstand und neuere klinische Aspekte. Fortschr Neurol Psychiatr 63: 173?193","journal-title":"Fortschr Neurol Psychiatr"},{"issue":"Suppl 1","key":"CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002018-199200071-00003","volume":"7","author":"JA Lieberman","year":"1992","unstructured":"Lieberman JA, Alvir JM (1992) A report on clozapine induced agranulocytosis in the United States. Drug Safety 7'[Suppl 1]: 1?2","journal-title":"Drug Safety"},{"key":"CR14","first-page":"1","volume-title":"Movement disorders","author":"CD Marsden","year":"1981","unstructured":"Marsden CD, Fahn S (1981) Problems in Parkinson's disease. In: Marsden CD, Fahn S (eds) Movement disorders. Butterworth Scientific, London, pp 1?7"},{"key":"CR15","first-page":"64","volume":"3","author":"HY Meltzer","year":"1995","unstructured":"Meltzer HY (1995) Role of serotonin in the action of atypical antipsychotic drugs. Clin Neurosci 3: 64?75","journal-title":"Clin Neurosci"},{"key":"CR16","first-page":"39","volume":"12","author":"HY Meltzer","year":"1995","unstructured":"Meltzer HY, Kennedy J, Dai J, Parsa M, Riley D (1995) Plasma clozapine levels and the treatment of L-DOPA-induced psychosis in Parkinson's disease. A high potency effect of clozapine. Neuropsychopharmacology 12: 39?45","journal-title":"Neuropsychopharmacology"},{"key":"CR17","first-page":"3047","volume":"51","author":"C Pfeiffer","year":"1994","unstructured":"Pfeiffer C, Wagner ML (1994) Clozapine therapy for Parkinson's disease and other movement disorders. Am J Hosp Pharm 51: 3047?3053","journal-title":"Am J Hosp Pharm"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF02251204","volume":"5","author":"MM Pinter","year":"1993","unstructured":"Pinter MM, Helscher RJ (1993) Therapeutic effect of clozapine in psychotic decompensation in idiopathic Parkinson's disease. J Neural Transm [PD Sect] 5: 135?146","journal-title":"J Neural Transm [PD Sect]"},{"issue":"Suppl 1","key":"CR19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00002018-199200071-00009","volume":"7","author":"AV Pisciotta","year":"1992","unstructured":"Pisciotta AV, Konings SA, Ciesemier LL, Cronkite CE, Lieberman JA (1992) On the possible mechanisms and predictability of clozapine induced agranulocytosis. Drug Safety 7 [Suppl 1]: 33?44","journal-title":"Drug Safety"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1212\/WNL.45.3.432","volume":"45","author":"JM Rebey","year":"1995","unstructured":"Rebey JM, Treves TA, Neufeld MY, Orlov E, Korczyn AD (1995) Low-dose clozapine in the treatment of levodopa-induced mental disturbances in Parkinson's disease. Neurology 45: 432?434","journal-title":"Neurology"},{"key":"CR21","first-page":"259","volume":"40","author":"R Rondot","year":"1984","unstructured":"Rondot R, deRecondo J, Coignet A, Ziegler M (1984) Mental disorders in Parkinson's disease after treatment with L-DOPA. Adv Neurol 40: 259?269","journal-title":"Adv Neurol"},{"issue":"Suppl 1","key":"CR22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2165\/00002018-199200071-00008","volume":"7","author":"PA Veys","year":"1992","unstructured":"Veys PA, Wilkes S, Shah SA, Noyelle R, Hoffbrand AV (1992) Clinical experience of clozapine-induced neutropenia in the UK: laboratory investigation using liquid culture systems and immunofluorocytometry. Durg Safety 7 [Suppl 1]: 26?32","journal-title":"Durg Safety"},{"key":"CR23","first-page":"257","volume":"5","author":"DD Webster","year":"1968","unstructured":"Webster DD (1968) Critical analysis of the disability in Parkinson's disease. Mod Treat 5: 257?282","journal-title":"Mod Treat"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01294731.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01294731\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01294731","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T07:18:44Z","timestamp":1556781524000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01294731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,11]]},"references-count":23,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[1997,11]]}},"alternative-id":["BF01294731"],"URL":"https:\/\/doi.org\/10.1007\/bf01294731","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,11]]}}}